PFE Stock Price Today: $43.00 Per Share

PFE Stock Overview

Pfizer Inc. (PFE) is a global biopharmaceutical company headquartered in New York, USA. It is one of the world's largest pharmaceutical companies by revenue and market capitalization, and it is a major player in the development, manufacturing, and distribution of a wide range of healthcare products and services.

• PFE stock closed at $43.00 per share on Monday, January 30, 2023, representing an increase of 2.37% from the previous trading day.
• The company has a market capitalization of approximately $245 billion, making it one of the most valuable pharmaceutical companies in the world.
• PFE stock has traded between $38.40 and $47.10 over the past 52 weeks.

Key Financial Metrics

Recent Developments

• In December 2022, Pfizer announced that it had received FDA approval for Paxlovid, an antiviral drug for the treatment of COVID-19.
• The company also announced in December 2022 that it had agreed to acquire Biohaven Pharmaceuticals, a company specializing in the development and commercialization of therapies for rare neurological disorders.
• In January 2023, Pfizer announced that it had entered into a collaboration with Moderna to develop and commercialize a next-generation, mRNA-based, personalized cancer vaccine.

Analysts' Recommendations

• The average analyst recommendation for PFE stock is "buy", with a consensus price target of $47.00 per share.
• Of the 25 analysts who cover PFE stock, 18 have issued a "buy" rating, 6 have issued a "hold" rating, and 1 has issued a "sell" rating.

Pros and Cons of Investing in PFE Stock

Pros:

• Pfizer is a global leader in the pharmaceutical industry.
• The company has a strong pipeline of promising new products.
• PFE stock is relatively undervalued compared to its peers.

Cons:

• The pharmaceutical industry is highly competitive, and there is no guarantee that Pfizer will continue to be successful in the long term.
• The company faces potential risks from patent expirations and regulatory changes.

Conclusion

Pfizer is a well-established and financially sound company with a strong track record of innovation and success. The company's recent developments and collaborations are positive signs for the future, and PFE stock appears to be attractively valued at current levels. However, it is important to remember that all investments carry risk, and investors should always do their own due diligence before making any investment decisions.

FAQs

• What is Pfizer's ticker symbol? PFE
• Where is Pfizer headquartered? New York, USA
• What is the market capitalization of Pfizer? Approximately $245 billion
• What is the consensus analyst price target for PFE stock? $47.00 per share
• Is Pfizer a good investment? PFE stock is relatively undervalued compared to its peers, and the company has a strong pipeline of promising new products. However, the pharmaceutical industry is highly competitive, and there is no guarantee that Pfizer will continue to be successful in the long term.